10 Takeover Targets to Watch This Fall

10 Takeover Targets to Watch This Fall

Invest with an Option to Buy: Bristol-Myers Squibb Partners with Accelerator BioMotiv

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!    Bristol-Myers Squibb has partnered with biotech accelerator BioMotiv. Bristol-Myers will become a limited partner, investing in projects of mutual interest, with an option to buy the companies once there is a preclinical candidate. “This new partnership will allow us to leverage the extensive expertise … Συνεχίστε να διαβάζετε Invest with an Option to Buy: Bristol-Myers Squibb Partners with Accelerator BioMotiv.

The top 10 drug launches of 2019

The top 10 drug launches of 2019